Navigation Links
Varian Medical Systems Establishes Radiotherapy Training Center and Clinical Help Desk in Tokyo, Japan

TOKYO, Jan. 11, 2012 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR), a world leader in radiotherapy equipment and software for the treatment of cancer, has established its first education center in Tokyo, Japan, to train radiation oncologists, medical physicists, and technologists who work with Varian's cancer treatment systems. In addition, the company has established a clinical contact center (Help Desk), to provide phone support for Varian's customers in Japan.

These services are housed in a new facility that is conveniently located in central Tokyo.  The training center will begin offering courses to radiation oncology clinical professionals in February 2012.  It features a computer-equipped classroom with 20 work stations and state of the art audio/visual equipment, as well as two customer lounges. 

"Radiotherapy is widely recognized as an efficient treatment for cancer.  The number of cancer patients who received radiotherapy treatments in Japan doubled over the last decade, rising from roughly 100,000 per year in the late 1990s to over 250,000 today," said Makoto Yamada, sales manager for Varian in Japan, citing statistics that have been published by the Japanese Society for Therapeutic Radiology and Oncology (JASTRO).  "JASTRO predicts that the number of Japanese people needing access to radiotherapy services will rise to 360,000 by 2015.  But there is a shortage of trained clinical professionals in Japan.  Varian's new education center represents our commitment to helping address the expanding need for training in this area." 

The field of radiation oncology has evolved over the last decade, and now requires the skillful use of complex technology that enables doctors to precisely target tumors while minimizing exposure of surrounding healthy tissues.  "Varian's training center will help clinicians develop the skills for using Varian technology to deliver advanced treatments like intensity-modulated radiotherapy, image-guided radiotherapy, and stereotactic radiosurgery," Mr. Yamada said. "The new Help Desk will then provide them with phone and e-mail support, whenever questions come up as they use Varian technology to treat patients."

"The addition of a dedicated Help Desk service is in keeping with Varian's commitment to expanding our support for the clinical oncology community of Japan," added Jon Hollon, Varian's director of worldwide training and education.  "Whereas in the past customers needing assistance sometimes had to wait for a return call from an applications specialist, they now can access a dedicated team of highly trained product experts during local business hours."

Varian's new offices are located at 5-1 Kabutocho Nihonhashi, Chuo-ku, Tokyo.  The first class scheduled in the new training center will take place in February, and will focus on Varian's Eclipse™ treatment planning software.  Additional courses are scheduled for March, April, and May, covering Eclipse operations plus the ARIA® oncology information system for managing cancer treatments.

"In the future, we will work with our clinical partners in Japan to develop courses on quality assurance procedures, safety, and the newest clinical modalities," Mr. Hollon said.  "Radiotherapy use is on the rise in Japan, and our goal is to provide world-class education and customer support on a local basis.  The new training center in Tokyo will help us customize our services to the specific needs of Japanese clinicians, and enable them to obtain training without leaving the country."

The Tokyo project is the sixth such education and training center established by Varian globally, following similar initiatives in Las Vegas (USA), Beijing (China), Zug (Switzerland), Buc (France), and Mumbai (India).

Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 5,700 people who are located at manufacturing sites in North America, Europe, and China and approximately 70 sales and support offices around the world. For more information, visit or follow us on Twitter.


JapanMeryl Ginsberg, (650) 424-6444

Tsuneo Kobayashi,

tsuneo.kobayashi@varian.comNote to editors: photos available at the following URL: click here.


SOURCE Varian Medical Systems
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
2. Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference
3. Clinical Studies of OvaRex in Advanced Ovarian Cancer Fail to Meet Primary Endpoint
4. Northwest Biotherapeutics Conducting Ovarian Cancer Clinical Trial With DCVax(R)-L at University of Pennsylvania
5. EntreMed Commences Phase 2 Study With MKC-1 in Ovarian/Endometrial Cancers
6. BioNumerik Commences Global Phase III Ovarian Cancer Trial on Novel Anticancer Drug Candidate Known as Karenitecin(R)
7. Sunesis Pharmaceuticals Reports Positive Interim Data for SNS-595 Single-Agent Activity in Platinum-Resistant Ovarian Cancer
8. Vermillions Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease
9. BSI-201 Demonstrates Significant Tumor Growth Inhibition and Increased Survival Rates in Preclinical Ovarian Cancer Studies
10. BiPar Sciences Expands Phase 2 Clinical Trials of BSI-201, a Novel DNA Repair Inhibitor, in Ovarian Cancer
11. Join NPRs David Ewing Duncan, Author Jessica Queller and a Panel of Medical and Legal Experts in a 90-Minute Webcast on Genetic Testing, Genomic Medicine and Breast & Ovarian Cancer
Post Your Comments:
(Date:11/26/2015)... Países Bajos, November 26, 2015 ... fotodinámica de Bremachlorin para el cáncer avanzado.   ... con la terapia fotodinámica de Bremachlorin para el cáncer ... enfoque combina la inmunoterapia con la terapia fotodinámica de ... Clinical Cancer Research . --> Clinical Cancer ...
(Date:11/26/2015)... Research and Markets ( ) has announced ... Outlook to 2019 - Rise in Cardiac Disorders and Growing ... to their offering. Boston ... scientific and others. --> The market ... Boston scientific and others. ...
(Date:11/26/2015)... , November 26, 2015 ... addition of the "2016 Future Horizons ... of Abuse Testing Market: Supplier Shares, Country ... report to their offering. --> ... the "2016 Future Horizons and Growth ...
Breaking Medicine Technology:
(Date:11/29/2015)... ... , ... Doctors who missed a case of mesothelioma in a 70-year-old Japanese ... push for a diagnosis, especially in people exposed to asbestos. Surviving Mesothelioma has just ... now. , Researchers at Gifu Prefectural Tajimi Hospital in Japan say the ...
(Date:11/28/2015)... ... November 28, 2015 , ... ... teleradiology services, has added Chris Hafey and Claude Hooton to its board of ... Society of North America (RSNA) 2015 Annual Meeting and continues to strategically transform ...
(Date:11/28/2015)... ... November 28, 2015 , ... Pixel Film Studios is back again with ... the possibilities are endless. Users have full control over angle of view, speed method, ... users are sure to get heads to turn. , ProPanel: Pulse offers fully customizable ...
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article ... way that they are handling security in light of the recent terrorist attacks in ... an attempt to stop an attack from reaching U.S. soil. Especially around special events ...
(Date:11/27/2015)... ... November 27, 2015 , ... "When ... said an inventor from Hillside, N.J. "Many people catch diseases simply from sitting ... individuals will always be protected from germs." , He developed the patent-pending QUDRATECS ...
Breaking Medicine News(10 mins):